Back
Harmony Biosciences Holdings Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
80
HRMY
Harmony Biosciences Holdings
Last Price:
38.96
Seasonality Move:
3.26%
Sell
28
ALNY
Alnylam Pharmaceuticals
Last Price:
276.54
Seasonality Move:
5.61%
Buy
80
Harmony Biosciences Holdings (HRMY)
is a Buy
Is Harmony Biosciences Holdings a Buy, Sell or Hold?
- The current Harmony Biosciences Holdings [HRMY] share price is $38.99. The Score for HRMY is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- HRMY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $276.33. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HRMY Stock Price Chart
What is Harmony Biosciences Holdings's stock price today?
-
The Harmony Biosciences Holdings share price today is $38.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HRMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $276.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
HRMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.12 | Buy |
| Relative Strength Index (14 RSI): | 67.35 | Buy |
| Chaikin Money Flow: | 129959 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.47 - 37.93) | Buy |
| Bollinger Bands (100): | (29.81 - 35.55) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.14 | Buy |
| Relative Strength Index (14 RSI): | 60.54 | Buy |
| Chaikin Money Flow: | -66637 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (256.89 - 278.47) | Buy |
| Bollinger Bands (100): | (164.63 - 269.71) | Buy |
HRMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.3 | Buy |
| 20-day SMA: | 36.91 | Buy |
| 50-day SMA: | 35.06 | Buy |
| 200-day SMA: | 32.22 | Buy |
| 8-day EMA: | 38.21 | Buy |
| 20-day EMA: | 37.11 | Buy |
| 50-day EMA: | 35.31 | Buy |
| 200-day EMA: | 33.08 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 267.42 | Buy |
| 20-day SMA: | 266.35 | Buy |
| 50-day SMA: | 259.79 | Buy |
| 200-day SMA: | 191.66 | Buy |
| 8-day EMA: | 269.14 | Buy |
| 20-day EMA: | 265.86 | Buy |
| 50-day EMA: | 253.52 | Buy |
| 200-day EMA: | 208.02 | Buy |
Harmony Biosciences Holdings Earnings Growth & HRMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.24 per share, a decrease this year of $0.14 per share, and an increase next year of $2.29 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Harmony Biosciences Holdings Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||